Equillium, Inc. (EQ) Stock Price, Quote & News - Stock Analysis (2024)

Equillium to be included in the Russell Microcap® Index Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata Equillium to Present at the Jefferies Global Healthcare Conference Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium Equillium to Host Analyst & Investor Day Equillium to Present at the JonesTrading 2023 Healthcare Summit Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates Equillium Announces $7.5 Million Share Repurchase Program Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation References